Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
Hereditary amyloidoses are rare and pose a diagnostic challenge. We report a case of hereditary amyloidosis associated with apolipoprotein C-II deposition in a 61-year-old female presenting with renal failure and nephrotic syndrome misdiagnosed as light chain amyloidosis. Renal biopsy was consistent...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2016/8690642 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832560408449253376 |
---|---|
author | Sadichhya Lohani Emily Schuiteman Lohit Garg Dhiraj Yadav Sami Zarouk |
author_facet | Sadichhya Lohani Emily Schuiteman Lohit Garg Dhiraj Yadav Sami Zarouk |
author_sort | Sadichhya Lohani |
collection | DOAJ |
description | Hereditary amyloidoses are rare and pose a diagnostic challenge. We report a case of hereditary amyloidosis associated with apolipoprotein C-II deposition in a 61-year-old female presenting with renal failure and nephrotic syndrome misdiagnosed as light chain amyloidosis. Renal biopsy was consistent with amyloidosis on microscopy; however, immunofluorescence was inconclusive for the type of amyloid protein. Monoclonal gammopathy evaluation revealed kappa light chain. Bone marrow biopsy revealed minimal involvement with amyloidosis with kappa monotypic plasma cells on flow cytometry. She was started on chemotherapy for light chain amyloidosis. She was referred to the Mayo clinic where laser microdissection and liquid chromatography mass spectrometry detected high levels of apolipoprotein C-II, making a definitive diagnosis. Apolipoprotein C-II is a component of very low-density lipoprotein and aggregates in lipid-free conditions to form amyloid fibrils. The identification of apolipoprotein C-II as the cause of amyloidosis cannot be solely made with routine microscopy or immunofluorescence. Further evaluation of biopsy specimens with laser microdissection and mass spectrometry and DNA sequencing of exons should be done routinely in patients with amyloidoses for definitive diagnosis. Our case highlights the importance of determining the subtype of amyloidosis that is critical for avoiding unnecessary therapy such as chemotherapy. |
format | Article |
id | doaj-art-a3f3ec988fe64a968f3ea8ea062845b4 |
institution | Kabale University |
issn | 2090-6641 2090-665X |
language | English |
publishDate | 2016-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Nephrology |
spelling | doaj-art-a3f3ec988fe64a968f3ea8ea062845b42025-02-03T01:27:36ZengWileyCase Reports in Nephrology2090-66412090-665X2016-01-01201610.1155/2016/86906428690642Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain AmyloidosisSadichhya Lohani0Emily Schuiteman1Lohit Garg2Dhiraj Yadav3Sami Zarouk4Department of Internal Medicine, Beaumont Health, Royal Oak, MI 48073, USADepartment of Internal Medicine, Beaumont Health, Royal Oak, MI 48073, USALehigh Valley Health Network, Allentown, PA 18103, USAUniversity Hospital Seidman Cancer Center, Case Western University, Cleveland, OH 44106, USADepartment of Nephrology, Beaumont Health, Royal Oak, MI 48073, USAHereditary amyloidoses are rare and pose a diagnostic challenge. We report a case of hereditary amyloidosis associated with apolipoprotein C-II deposition in a 61-year-old female presenting with renal failure and nephrotic syndrome misdiagnosed as light chain amyloidosis. Renal biopsy was consistent with amyloidosis on microscopy; however, immunofluorescence was inconclusive for the type of amyloid protein. Monoclonal gammopathy evaluation revealed kappa light chain. Bone marrow biopsy revealed minimal involvement with amyloidosis with kappa monotypic plasma cells on flow cytometry. She was started on chemotherapy for light chain amyloidosis. She was referred to the Mayo clinic where laser microdissection and liquid chromatography mass spectrometry detected high levels of apolipoprotein C-II, making a definitive diagnosis. Apolipoprotein C-II is a component of very low-density lipoprotein and aggregates in lipid-free conditions to form amyloid fibrils. The identification of apolipoprotein C-II as the cause of amyloidosis cannot be solely made with routine microscopy or immunofluorescence. Further evaluation of biopsy specimens with laser microdissection and mass spectrometry and DNA sequencing of exons should be done routinely in patients with amyloidoses for definitive diagnosis. Our case highlights the importance of determining the subtype of amyloidosis that is critical for avoiding unnecessary therapy such as chemotherapy.http://dx.doi.org/10.1155/2016/8690642 |
spellingShingle | Sadichhya Lohani Emily Schuiteman Lohit Garg Dhiraj Yadav Sami Zarouk Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis Case Reports in Nephrology |
title | Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis |
title_full | Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis |
title_fullStr | Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis |
title_full_unstemmed | Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis |
title_short | Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis |
title_sort | apolipoprotein c ii deposition amyloidosis a potential misdiagnosis as light chain amyloidosis |
url | http://dx.doi.org/10.1155/2016/8690642 |
work_keys_str_mv | AT sadichhyalohani apolipoproteinciidepositionamyloidosisapotentialmisdiagnosisaslightchainamyloidosis AT emilyschuiteman apolipoproteinciidepositionamyloidosisapotentialmisdiagnosisaslightchainamyloidosis AT lohitgarg apolipoproteinciidepositionamyloidosisapotentialmisdiagnosisaslightchainamyloidosis AT dhirajyadav apolipoproteinciidepositionamyloidosisapotentialmisdiagnosisaslightchainamyloidosis AT samizarouk apolipoproteinciidepositionamyloidosisapotentialmisdiagnosisaslightchainamyloidosis |